SCM Lifescience Co., Ltd. (KOSDAQ:298060)
South Korea · Delayed Price · Currency is KRW 824.00
+5.00 (0.61%)
At close: Jan 28, 2026
SCM Lifescience Market Cap
SCM Lifescience has a market cap or net worth of 36.34 billion as of January 30, 2026. Its market cap has decreased by -7.44% in one year.
Market Cap
36.34B
Enterprise Value
27.44B
Revenue
1.54B
Ranking
n/a
PE Ratio
n/a
Stock Price
824.00
Market Cap Chart
Since June 17, 2020, SCM Lifescience's market cap has decreased from 398.06B to 36.34B, a decrease of -90.87%. That is a compound annual growth rate of -34.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 36.34B | -18.77% |
| Dec 30, 2025 | 44.73B | 15.58% |
| Dec 30, 2024 | 38.70B | -49.97% |
| Dec 28, 2023 | 77.37B | -55.83% |
| Dec 29, 2022 | 175.14B | -25.10% |
| Dec 30, 2021 | 233.83B | -60.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MOA Life Plus | 68.67B |
| EyeGene | 68.48B |
| SunBio,Inc. | 67.92B |
| NGeneBio | 50.45B |
| J2KBIO | 49.65B |
| Aptamer Sciences | 47.42B |
| Kainos Medicine | 35.56B |
| Epibiotech | 33.45B |